BioPharma Credit (LON:BPCR) Shares Up 0.4% - Time to Buy?

BioPharma Credit (LON:BPCR - Get Free Report) was up 0.4% during mid-day trading on Tuesday . The company traded as high as GBX 0.91 ($0.01) and last traded at GBX 0.91 ($0.01). Approximately 394,539 shares were traded during trading, a decline of 55% from the average daily volume of 878,212 shares. The stock had previously closed at GBX 0.91 ($0.01).

BioPharma Credit Price Performance

The company has a market cap of £1.08 billion, a P/E ratio of 10.34 and a beta of 0.22. The stock has a fifty day moving average price of GBX 0.87 and a two-hundred day moving average price of GBX 0.87.

BioPharma Credit Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, May 7th. Investors of record on Thursday, April 3rd were issued a dividend of $0.02 per share. This represents a yield of 1.99%. The ex-dividend date of this dividend was Thursday, April 3rd. BioPharma Credit's payout ratio is 7,957.15%.

BioPharma Credit Company Profile

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.